Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)
Status:
Completed
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to show superiority of vilaprisan in the treatment of
heavy menstrual bleeding (HMB) in subjects with uterine fibroids compared to placebo
The secondary objectives of this study were to additionally evaluate the efficacy and safety
of vilaprisan in subjects with uterine fibroids